Find

Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Gregersen, M., Andersen, K. V., Lisby, M., Tei, R. M. H. & Mainz, H. (2023). Prevalence of Missed Nursing Care at a University Hospital – a Survey. Abstract from The 19th EuGMS Congress, Helsinki, Finland.

Grønbæk, H., Mellemkjær, A., Nielsen, S. & Magkos, F. (2023). The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction-associated steatotic liver disease. Hepatobiliary Surgery and Nutrition, 12(6). https://doi.org/10.21037/hbsn-23-552

Grove-Laugesen, D., Ebbehoj, E., Watt, T., Riis, A. L., Østergård, T., Bruun, B. J., Hansen, K. W. & Rejnmark, L. (2023). Effect of Vitamin D Supplementation on Graves' Disease: The DAGMAR Trial. Thyroid : official journal of the American Thyroid Association, 33(9), 1110-1118. https://doi.org/10.1089/thy.2023.0111

Gude, M. F., Hjortebjerg, R., Bjerre, M., Charles, M. H., Witte, D. R., Sandbæk, A. & Frystyk, J. (2023). The STC2–PAPP-A–IGFBP4–IGF1 axis and its associations to mortality and CVD in T2D. Endocrine Connections, 12(3), Article e220451. https://doi.org/10.1530/EC-22-0451

Gullaksen, S. (2023). Effects of 32 weeks treatment with semaglutide and empagliflozin on magnetic resonance imaging derived kidney parameters and on retinal function in people with type 2 diabetes: data from a randomised trial. [PhD dissertation, Aarhus University].

Gullaksen, S., Vernstrøm, L., Sørensen, S. S., Funck, K. L., Petersen, L., Bek, T., Laugesen, E. & Poulsen, P. L. (2023). Effects of 32 weeks' treatment with semaglutide, empagliflozin or the combination on retinal oxygenation, vessel diameter and central retinal thickness. Diabetologia, 66 (Sup1)(1–536 (2023)). https://doi.org/10.1007/s00125-023-05969-6

Gullaksen, S., Vernstrøm, L., Sørensen, S. S., Funck, K. L., Petersen, L., Bek, T., Poulsen, P. L. & Laugesen, E. (2023). Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial. Journal of Diabetes and its Complications, 37(5), 1-7. Article 108472. https://doi.org/10.1016/j.jdiacomp.2023.108472

Gullaksen, S., Vernstrøm, L., Sørensen, S. S., Ringgaard, S., Laustsen, C., Funck, K. L., Poulsen, P. L. & Laugesen, E. (2023). Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial. Diabetologia, 66(5), 813-825. https://doi.org/10.1007/s00125-023-05876-w

Gundersen, T. W., Ebbehoj, A., Knorr, S., Jensen, D. M., Damm, P., Løkkegaard, E. C. L., Mathiesen, E. R., Thomsen, R. W. & Clausen, T. D. (2023). Validation of Danish registry-cases of type 1 diabetes in women giving live birth using a clinical cohort as gold standard. Endocrinology, Diabetes & Metabolism, 6(1), Article e374. https://doi.org/10.1002/edm2.374

Hærvig, K. K., Petersen, K. U., Hougaard, K. S., Lindh, C., Ramlau-Hansen, C. H., Toft, G., Giwercman, A., Høyer, B. B., Flachs, E. M., Bonde, J. P. & Tøttenborg, S. S. (2023). Response to "Comment on 'Maternal Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Male Reproductive Function in Young Adulthood: Combined Exposure to Seven PFAS'". Environmental Health Perspectives, 131(1), Article 018004. https://doi.org/10.1289/EHP12600

Displaying results 801 to 810 out of 4018

81

Revised 11.09.2025

-

Department of Clinical Medicine